Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BCLC Stage C Hepatocellular Carcinoma”

43 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 43 results

Testing effectiveness (Phase 2)Looking for participantsNCT05992220
What this trial is testing

Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerHepatocellular Carcinoma Non-resectable+2 more
Asan Medical Center 138
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06685354
What this trial is testing

Sequential T and I With H101 Via HAI for BCLC C Stage HCC: A Prospective Single-Center Single-Arm Pilot Study

Who this might be right for
Hepatocellular Carcinoma (HCC)
Henan Cancer Hospital 11
Early research (Phase 1)Study completedNCT02578602
What this trial is testing

MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaBCLC Stage 0 Adult Hepatocellular Carcinoma+6 more
University of Southern California 26
Testing effectiveness (Phase 2)UnknownNCT03520257
What this trial is testing

The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular Carcinoma
Guangxi Medical University 50
Large-scale testing (Phase 3)UnknownNCT04909866
What this trial is testing

The Efficacy and Safety of TACE, Lenvatinib and Camrelizumab in the Treatment of BCLC Stage B/C Hepatocellular Carcinoma: a Single-arm, Single-center, Open-label Study

Who this might be right for
Hepatocellular Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 40
Not applicableNot Yet RecruitingNCT06971237
What this trial is testing

SIRT and Peri-immunotherapy : a New Concept

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC), Classified as BCLC Stage B or C, Treated With a Combination of Selective Internal Radiation Therapy
Assistance Publique - Hôpitaux de Paris 60
Not applicableStudy completedNCT06631326
What this trial is testing

HAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416)

Who this might be right for
HCC - Hepatocellular CarcinomaHepatic Arterial Infusion ChemotherapyBCLC Stage C Hepatocellular Carcinoma+2 more
First Hospital of China Medical University 244
Not applicableStudy completedNCT07368530
What this trial is testing

Using Machine Learning to Identify Responders to TACE or HAIC for uHCC

Who this might be right for
Unresectable Hepatocellular Carcinoma (HCC)BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma
First Affiliated Hospital, Sun Yat-Sen University 3,000
Testing effectiveness (Phase 2)UnknownNCT04796025
What this trial is testing

TACE Combined With Sintilimab Plus Bevacizumab Biosimilar in Hepatocellular Carcinoma (BCLC-C Stage ): a Prospective Single-arm Phase II Clinical Study

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 34
Early research (Phase 1)Study completedNCT01666756
What this trial is testing

Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerAdvanced Adult Hepatocellular Carcinoma+2 more
City of Hope Medical Center 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT04483284
What this trial is testing

Study of TACE Combined With Camrelizumab in the Treatment of HCC Patients

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 28
Testing effectiveness (Phase 2)Study completedNCT02940496
What this trial is testing

Pembrolizumab (MK-3475) in Hepatocellular Carcinoma

Who this might be right for
BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaHepatitis C Infection+8 more
M.D. Anderson Cancer Center 15
Testing effectiveness (Phase 2)Ended earlyNCT05199285
What this trial is testing

A Phase II Study of Nivolumab + Ipilimumab in Advanced HCC Patients Who Have Progressed on First Line Atezolizumab + Bevacizumab

Who this might be right for
BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaLocally Advanced Hepatocellular Carcinoma+8 more
Academic and Community Cancer Research United 15
Testing effectiveness (Phase 2)UnknownNCT04191889
What this trial is testing

A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification

Who this might be right for
C-staged Hepatocellular Carcinoma in BCLC Classification
Sun Yat-sen University 47
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05507632
What this trial is testing

Donafenib Plus Sintilimab in Combination With TACE in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Unresectable Hepatocellular Carcinoma
Nanfang Hospital, Southern Medical University 48
Testing effectiveness (Phase 2)UnknownNCT04992143
What this trial is testing

TACE+Tilelizumab+Sorafenib in the Treatment of BCLC Stage C HCC

Who this might be right for
BCLC Stage C Hepatocellular Carcinoma
First Affiliated Hospital of Zhejiang University 20
Testing effectiveness (Phase 2)WithdrawnNCT05327738
What this trial is testing

Yttrium Y 90 Glass Microspheres, Atezolizumab, and Cabozantinib for the Treatment of Unresectable or Locally Advanced Hepatocellular Carcinoma

Who this might be right for
BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaLocally Advanced Hepatocellular Carcinoma+2 more
OHSU Knight Cancer Institute
Very early researchStudy completedNCT05250895
What this trial is testing

BOLD MRI and FMISO PET for the Assessment of Hypoxic Tumor Microenvironment in Patients with Oligometastatic Liver Cancer Undergoing Yttirum-90 Selective Internal Radiation Therapy

Who this might be right for
BCLC Stage a Hepatocellular CarcinomaBCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma+1 more
Emory University 9
Large-scale testing (Phase 3)Study completedNCT03164382
What this trial is testing

Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma

Who this might be right for
Liver CancerHepatic Carcinoma
Sun Yat-sen University 262
Testing effectiveness (Phase 2)Study completedNCT01900002
What this trial is testing

Sorafenib Tosylate and Yttrium Y 90 Glass Microspheres in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Advanced Adult Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaRecurrent Adult Hepatocellular Carcinoma+8 more
M.D. Anderson Cancer Center 40
Load More Results